about
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infectionInfectious diseases: annual review of significant publicationsSuppressive effect of bacterial endotoxin on the expression of cell-mediated anti-Listeria immunity.Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous mediumBiological activities of endotoxins detoxified by alkylationCell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.Strain-dependent cytotoxic effects of endotoxin for mouse peritoneal macrophagesUse of immune modulators in nonspecific therapy of bacterial infections.Cyclic AMP inhibition of lipopolysaccharide-induced restriction of Legionella pneumophila growth in macrophage cultures.Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.Resistance to meningococcemia apparently conferred by anti-H.8 monoclonal antibody is due to contaminating endotoxin and not to specific immunoprotectionAn overview on interleukin-1 as a therapeutic agent.Options for the treatment of serious infections with interleukin-1.Vaccines and cell-mediated immunity.Expression of the natural resistance gene Lsh in resident liver macrophages.Cytokines in the treatment of fungal infections.Increased resistance and depressed delayed-type hypersensitivity to Listeria monocytogenes induced by pretreatment with lipopolysaccharide.Interleukin-1 as a possible agent for treatment of infection.Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections.Enhanced phagocytosis and bactericidal activity of hepatic reticuloendothelial system during endotoxin tolerancePotentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing miceThe effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection.Innate Immune Memory: Time for Adopting a Correct Terminology.Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.
P2860
Q24654068-E72818E3-D4D2-491D-8501-69A50DECE8E0Q27486430-61477304-157B-4FBD-9A84-5E7D75FFE585Q34085041-B1C16648-D012-43FE-8C77-C00B577B076CQ34085920-D3E0A6C0-5381-46C1-AC89-120E1DFCB5D1Q34127925-D9CC732C-6730-4A3C-B892-451E7B1D752CQ34175864-7A2C8A13-191C-45FA-9303-4787A28E8F21Q34451189-5B648877-7535-42AC-90B7-55FD41915A14Q36133627-D0E2372B-727E-4E57-BDD8-7D0352913F0DQ36945024-25A5243C-5018-4C73-A55F-1D5385767C7AQ36981981-CE33C4E4-FCD8-4A41-91EC-1ACBF2845163Q37021932-2B3C12C4-52EC-403B-8B2B-E6B8D78CF41BQ38789477-B538CF0D-57F2-4F52-8FA6-55A8ED4A9350Q38789510-DB7B290F-24C8-4D34-9D93-BBEEFE492E93Q39950952-1A1C18A6-59B1-4836-9907-29318D973A60Q40181622-945411D8-0080-4775-8015-3FF85172170EQ40598683-89F82310-F938-49BF-A5CD-B3D1C6F7EC5AQ40615893-87CEB772-6F50-4BC1-A26C-40706F5D459EQ40899109-68FA91E1-AC6B-473D-B59A-C78C10890BABQ40901849-DF3C878E-03B6-4602-ADB8-462CFE826929Q41158445-690046FD-4118-45E3-A74F-3598906EFFC6Q41481329-3D9BB57D-04A3-4F0E-9ED7-07F3C727C67DQ41872712-9A9D9389-8F51-4A1C-B984-6CA7135C3BBAQ53688056-5DF0F9D9-3D4D-40A8-BBC6-338AF9A96E0EQ54380601-EC38E259-523A-4237-A70A-89C67B282583
P2860
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Effects of endotoxins on susceptibility to infections.
@en
Effects of endotoxins on susceptibility to infections.
@nl
type
label
Effects of endotoxins on susceptibility to infections.
@en
Effects of endotoxins on susceptibility to infections.
@nl
prefLabel
Effects of endotoxins on susceptibility to infections.
@en
Effects of endotoxins on susceptibility to infections.
@nl
P356
P1476
Effects of endotoxins on susceptibility to infections.
@en
P2093
P304
P356
10.1093/INFDIS/122.3.205
P407
P577
1970-09-01T00:00:00Z